Bucharest, Romania

Gabriela Negroiu

This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriela Negroiu. Retrieved from https://idiyas.com/inventor/gabriela-negroiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriela Negroiu: Innovator in Tumor Treatment

Introduction

Gabriela Negroiu is a prominent inventor based in Bucharest, Romania. She has made significant contributions to the field of medical research, particularly in the treatment of tumors. Her innovative approach has led to the development of a unique patent that addresses critical health challenges.

Latest Patents

Gabriela holds a patent for the "Iminosugar treatment of tumors." This patent describes a method where the proliferation of cells can be reduced by contacting them with a compound having a specific formula. The formula includes alkyl groups and can be utilized for treating tumors, including melanoma. Additionally, the compounds can reduce the secretion of matrix metalloproteinase (MMP) enzymes, which are associated with elevated levels in various physiological conditions, including tumors.

Career Highlights

Gabriela is affiliated with Oxford University Innovation Limited, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on cancer treatment and the broader medical community.

Collaborations

Gabriela has collaborated with notable colleagues, including Raymond A. Dwek and Wanda Buzgariu. These partnerships have enriched her research and contributed to the development of her innovative solutions.

Conclusion

Gabriela Negroiu's work exemplifies the spirit of innovation in medical research. Her contributions to tumor treatment through her patented methods highlight the importance of scientific advancement in addressing critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…